2013 | A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy | BREAST |
2019 | A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
| CANCER RESEARCH AND TREATMENT |
2023 | A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
2019 | Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30
| BREAST CANCER RESEARCH |
2015 | Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication
| PLOS ONE |
2011 | Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
| ANNALS OF ONCOLOGY |
2019 | Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2018 | Association between Changes in Serum 25-Hydroxyvitamin D Levels and Survival in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
| JOURNAL OF BREAST CANCER |
2011 | Association between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatment
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2016 | Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women
| MEDICINE |
2019 | Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study
| SCIENTIFIC REPORTS |
2021 | Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer
| INTERNATIONAL JOURNAL OF CANCER |
2022 | Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2022 | Body composition change during neoadjuvant chemotherapy for breast cancer
| FRONTIERS IN ONCOLOGY |
2012 | Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization
| CANCER |
2024 | Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study
| INTERNATIONAL JOURNAL OF SURGERY |
2018 | Can Biannual Ultrasound Surveillance Detect Smaller Second Cancers or Detect Cancers Earlier in Patients with Breast Cancer History? | ULTRASOUND IN MEDICINE AND BIOLOGY |
2018 | CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
| ONCOTARGET |
2021 | Change in Shoulder Function in the Early Recovery Phase after Breast Cancer Surgery: A Prospective Observational Study
| JOURNAL OF CLINICAL MEDICINE |
2023 | Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer
| KOREAN JOURNAL OF RADIOLOGY |
2012 | Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry | BREAST |
2015 | Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
| YONSEI MEDICAL JOURNAL |
2017 | Chemotherapy-induced irreversible alopecia in early breast cancer patients | BREAST CANCER RESEARCH AND TREATMENT |
2019 | Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study | Breast Cancer Research and Treatment |
2011 | Clinical Significance of Age at the Time of Diagnosis among Young Breast Cancer Patients
| JOURNAL OF BREAST CANCER |
2011 | Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2010 | Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast.
| YONSEI MEDICAL JOURNAL |
2008 | Clinicopathological characteristics of male breast cancer.
| YONSEI MEDICAL JOURNAL |
2010 | Clinicopathological Characteristics of Mucinous Carcinoma of the Breast in Korea: Comparison with Invasive Ductal Carcinoma-Not Otherwise Specified
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Clinicopathological Features and Prognosis of Lobular Carcinoma In Situ
| Journal of Breast Disease |
2010 | Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
2017 | Comparison of characteristics in patients with both thyroid and breast cancer: Based on order of incidence
| Korean Journal of Clinical Oncology (대한임상종양학회지) |
2011 | Comparison of treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation in patients with one to three positive axillary lymph nodes | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2016 | Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy
| YONSEI MEDICAL JOURNAL |
2020 | Conserving the lymphatics from the arm using fluorescence imaging in patients with breast cancer at high risk of postoperative lymphedema: a pilot study
| GLAND SURGERY |
2023 | Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE |
2012 | Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. | BREAST CANCER RESEARCH AND TREATMENT |
2011 | Dermatofibrosarcoma protuberans arising on the skin of the breast | BREAST JOURNAL |
2020 | Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors
| BMC CANCER |
2017 | Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR
| YONSEI MEDICAL JOURNAL |
2020 | Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study | CANCER |
2017 | Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study | EUROPEAN JOURNAL OF CANCER |
2023 | Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy | ANNALS OF SURGICAL ONCOLOGY |
2022 | Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
| BREAST |
2017 | Does the type of anesthesia really affect the recurrence-free survival after breast cancer surgery?
| ONCOTARGET |
2019 | Early experiences with robot-assisted prosthetic breast reconstruction
| Archives of Plastic Surgery |
2023 | Effect of a 1-year tailored exercise program according to cancer trajectories in patients with breast cancer: study protocol for a randomized controlled trial
| BMC CANCER |
2019 | Effect of primary tumor resection on overall survival in patients with stage IV breast cancer | BREAST JOURNAL |
2022 | Effects of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors: A randomized controlled trial | PSYCHO-ONCOLOGY |
2017 | Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
2017 | Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial
| PLOS ONE |
2013 | Efficacy of a combined alendronate and calcitriol agent (Maxmarvil?) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study
| ENDOCRINE JOURNAL |
2023 | Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
| CANCER RESEARCH AND TREATMENT |
2013 | Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer
| ANNALS OF ONCOLOGY |
2013 | Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers. | BREAST CANCER RESEARCH AND TREATMENT |
2019 | Establishment of Chemosensitivity Tests in Triple-Negative and BRCA-mutated Breast Cancer Patient-Derived Xenograft Models
| PLOS ONE |
2015 | Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer
| JOURNAL OF BREAST CANCER |
2015 | Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy | ACTA RADIOLOGICA |
2010 | Expression of androgen receptors in primary breast cancer
| ANNALS OF ONCOLOGY |
2016 | Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
| JOURNAL OF BREAST CANCER |